Faculty profile

Ruxandra Pinto

ResearcherInfectious Diseases/Internal MedicineUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Ruxandra Pinto

Researcher

Infectious Diseases/Internal Medicine

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
50 publications in the last five years, latest in 2026.
Principal investigator on 1 research grant (1 CIHR), most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

156

Publications

2,721

Citations

210

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Adaptive Platform Trial Antibiotic De-Escalation Antibiotic Duration Antibiotic Oral Switch Antimicrobial Resistance Bloodstream Infection Central Venous Catheter Infection Gram Negative Bacteremia

Latest papers

Accounting for non-adherence to assigned antibiotic treatment duration for bloodstream infection (BALANCE): a post-hoc analysis of a randomised clinical trial
The Lancet Infectious Diseases · 2026
Procalcitonin to Guide 7 vs 14 Days of Antibiotics in Bloodstream Infections
JAMA Network Open · 2026
Comparing different methods for analysing hierarchical composite endpoints: two illustrative case studies with post hoc analyses of the BALANCE (Bacteraemia Antibiotic Length Actually Needed for Clinical Effectiveness) and CAMERA2 (Combination Antibiotics for methicillin-resistant Staphylococcus aureus) randomized clinical trials
Clinical Microbiology and Infection (CMI) · 2026

All 156 publications

Latest funding

OVATION-CEPEC: Optimal VAsopressor titraTION within the Canadian Critical Care Comparative Effectiveness Platform(e) d'Évaluation Clinique Comparée en soins Critiques (CEPEC)
CIHR · 2025 · Co-investigator
$3,021,752
BALANCE+: A Platform Trial for Gram Negative Bloodstream Infections
CIHR · 2025 · Principal investigator
$1,908,674
The impact of experiencing maternal violent injury on health outcomes in youth: an evaluation of health system impact and needs.
CIHR · 2023 · Co-investigator
$97,924

All 12 grants and awards

From the 150 most recent of 156 publications.

Accounting for non-adherence to assigned antibiotic treatment duration for bloodstream infection (BALANCE): a post-hoc analysis of a randomised clinical trial

Ong SWX, Pinto R, Mahar RK, Rishu A, Davis JS, Fowler RA, Tong SYC, Daneman N, consortium BT, Rogers B

The Lancet Infectious Diseases20263 citations

DOI: 10.1016/s1473-3099(25)00592-4

Procalcitonin to Guide 7 vs 14 Days of Antibiotics in Bloodstream Infections

Ramendra R, Wright JK, Kain KC, Kim B, Mishra H, Zhong K, Aslanian P, Carignan A, Conly J, Detsky M

JAMA Network Open20262 citations

DOI: 10.1001/jamanetworkopen.2026.20973

Comparing different methods for analysing hierarchical composite endpoints: two illustrative case studies with post hoc analyses of the BALANCE (Bacteraemia Antibiotic Length Actually Needed for Clinical Effectiveness) and CAMERA2 (Combination Antibiotics for methicillin-resistant Staphylococcus aureus) randomized clinical trials

Ong SWX, Pinto R, Mahar RK, Petersiel N, Fowler RA, Davis JS, Daneman N, Tong SYC, Lye DC, Yahav D

Clinical Microbiology and Infection (CMI)20262 citations

DOI: 10.1016/j.cmi.2025.11.027

Duration of antibiotic therapy for bacteremia in immune compromised hosts—a post hoc subgroup analysis of the BALANCE randomized clinical trial

Hamani M, Pinto R, Lee TC, MacFadden D, McDonald EG, Sligl W, Fowler RA, Daneman N, consortium TB, Daneman N

Clinical Microbiology and Infection (CMI)20261 citations

DOI: 10.1016/j.cmi.2026.06.003

Duration of Therapy for Pseudomonas aeruginosa Bacteremia—A Post Hoc Subgroup Analysis From the BALANCE Randomized Controlled Trial

Yahav D, Pinto R, Cook D, Davis J, Duan E, Hoffman T, Lee TC, McDonald EG, Morpeth S, Muscedere J

Clinical Infectious Diseases20261 citations

DOI: 10.1093/cid/ciag144

Association of anti-anaerobic antibiotics with mortality and the gut microbiome: a sub-study of the BALANCE randomized clinical trial

Armstrong E, Pinto R, Kulikova M, Yee NR, Rishu A, Muscedere J, Sibley S, Maslove DM, Boyd JG, Evans GA

Clinical Infectious Diseases2026

DOI: 10.1093/cid/ciag460

Hierarchical composite endpoints provide a flexible framework to ensure clinical trials measure outcomes important to all stakeholders.

Ong SWX, Mahar RK, Selman CJ, Pinto R, Davis JS, Fowler RA, Tong SYC, Daneman N

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America2026

DOI: 10.1093/cid/ciag277 PMID: 42015555

Selective Decontamination of the Digestive Tract during Ventilation in the ICU.

SuDDICU Investigators for the Australia and New Zealand Intensive Care Society Clinical Trials Group and the Canadian Critical Care Trials Group, Cuthbertson BH, Billot L, Campbell MK, Daneman N, Davis JS, Delaney A, Devaux A, Ferguson ND, Finfer SR, Fowler R, Gordon AC, Hammond NE, Klein G, Li Q, Marshall J, Micallef S, Murthy S, Mysore J, Naik C, Patel C, Pinto R, Rose L, Seppelt IM, Venkatesh B, Young PJ, Myburgh JA, The SuDDICU Investigators for the Australia and New Zealand Intensive Care Society Clinical Trials Group and the Canadian Critical Care Trials Group

The New England journal of medicine2026

DOI: 10.1056/nejmoa2506398 PMID: 41159880

Rapid cycle deliberate practice: a complement to clinical exposure in critical care education.

Manetti Previero B, Spataru A, Pinto R, Piquette D

ATS scholar2026

DOI: 10.1093/atsscholar/aapaf003 PMID: 41818783

Trends in Use of IV Vitamin C Among Patients With Sepsis.

Segall RE, Lamontagne F, Vail EA, Wunsch H, Bosch NA, Walkey AJ, Pinto R, Gershengorn HB, Adhikari NKJ

Critical care medicine2026

DOI: 10.1097/ccm.0000000000007003 PMID: 41452227

Something wrong or missing on this profile? Suggest a correction

Ruxandra Pinto

Research

Latest papers

Latest funding

Accounting for non-adherence to assigned antibiotic treatment duration for bloodstream infection (BALANCE): a post-hoc analysis of a randomised clinical trial

Procalcitonin to Guide 7 vs 14 Days of Antibiotics in Bloodstream Infections

Duration of antibiotic therapy for bacteremia in immune compromised hosts—a post hoc subgroup analysis of the BALANCE randomized clinical trial

Duration of Therapy for Pseudomonas aeruginosa Bacteremia—A Post Hoc Subgroup Analysis From the BALANCE Randomized Controlled Trial

Association of anti-anaerobic antibiotics with mortality and the gut microbiome: a sub-study of the BALANCE randomized clinical trial

Hierarchical composite endpoints provide a flexible framework to ensure clinical trials measure outcomes important to all stakeholders.

Selective Decontamination of the Digestive Tract during Ventilation in the ICU.

Rapid cycle deliberate practice: a complement to clinical exposure in critical care education.

Trends in Use of IV Vitamin C Among Patients With Sepsis.

Frequent collaborators

Nick Daneman

Deborah Cook

Hannah Wunsch

John Muscedere

Jennifer Tsang

Sangeeta Mehta

Srinivas Murthy

Emilie Belley-Cote

Gordon Guyatt

Marc Jeschke

Robert Fowler

Louise Rose

Francois Lamontagne

Lauralyn McIntyre

Erick Duan

Jeannie Callum

Kazuyoshi Aoyama

Paul Dorian

Sheldon Cheskes

Peter Dodek

Peter Daley

Gary Garber

Michael Silverman

Jennifer Grant

Cecilia Costiniuk

Bram Rochwerg

Alexis Turgeon

Wendy Sligl

Lisa Dolovich

Naheed Jivraj

Leasa Knechtel

Ian Witterick

David Wong

Ayah Nayfeh

Michael Silverman

Ian Ball

Howard Lampe

Ameeta Singh

Bijan Teja

Santiago Perez Patrigeon